Business Wire
-
Valar Labs Announces Validation Of First Histology-Based Test To Predict Response To BCG In Bladder Cancer
5/1/2024
Valar Labs, the developer of computational histology AI tests for predicting response to cancer therapies, announced new data today which is being presented on Saturday, May 4, 2024 at the 2024 Annual Meeting of the American Urological Association (AUA) as a podium presentation (PD30-03).
-
C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity Blood Testing For Alzheimer’s Disease And Brain Research Market
4/26/2024
C₂N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a partnership agreement with Mediford Corporation, a PHC Holdings Corporation (TSE 6523) Group Company and premier provider of clinical research to the biopharma industry throughout Japan.
-
Empowering Innovation: StatLab Welcomes Scientific Device Laboratory Into Family
4/25/2024
StatLab Medical Products (“StatLab”), a leading developer and manufacturer of medical diagnostic supplies and equipment, today announced the acquisition of Scientific Device Laboratory (“SDL”), a Chicago-based manufacturer of printed diagnostic slides and a variety of consumables and kits for the anatomic pathology and microbiology markets.
-
Revvity Unveils A New Era Of Automated Tuberculosis Testing
4/24/2024
Revvity, Inc.today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is easy to use and designed to provide efficient workflows in the lab.
-
Clarapath Forms Strategic Collaboration With Mayo Clinic To Advance Pathology Tissue Processing
4/23/2024
Clarapath, a medical robotics company transforming the way pathology laboratories process tissue, announced it has entered into a strategic collaboration with Mayo Clinic to propel a new era of laboratory automation.
-
Sapio Sciences Launches New Multimodal Registration Capabilities For Its Lab Informatics Platform
4/23/2024
Sapio Sciences, the science-aware lab informatics platform, today announced the launch of its new multimodal registration capabilities.
-
Thermo Fisher Scientific Launches New ENERGY STAR Certified TSX Universal Series ULT Freezers To Deliver Tighter Temperature Control And Faster Recovery Times
4/8/2024
Building on 80 years of expertise engineering cold storage lab equipment, Thermo Fisher Scientific today introduces its newest line of high performance, ultra-low temperature (ULT) freezers.
-
Nucleai And GoPath Diagnostics Announce Strategic Collaboration To Provide Integrated AI-Powered Digital Pathology Solutions For Clinical Research And Diagnostic Applications
4/8/2024
Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, today announced a strategic collaboration with GoPath Diagnostics, a leading full-service digital pathology and molecular diagnostics laboratory.
-
Sebia Receives U.S. FDA Clearance For The CAPILLARYS 3 DBS Devices
4/5/2024
Sebia, a global specialty diagnostic company providing innovative solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and autoimmune diseases, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for CAPILLARYS 3 DBS devices.
-
Descartes Labs Accelerates Growth With Strategic Acquisition Of Geosite
4/2/2024
Descartes Labs, a leading provider of geospatial analytics and artificial intelligence solutions, announced today that it acquired all of the operating assets of Geosite, a SaaS provider of geospatial intelligence to property and casualty insurance companies.